Latest Press Releases
As interest in at-home NAD+ options grows in 2026, this Pallas Health comparison explores the brand-stated daily nasal spray and weekly injection, current pricing, clinician-guided prescription process, and the practical differences consumers may want to compare before choosing which format best fits their routine.
As adults take a more serious look at GLP-1 weight-management care in 2026, this Pallas Health review examines its doctor-led telehealth model, compounded semaglutide and tirzepatide options, FDA-approved brand-name pathways, current pricing, and what consumers should compare before beginning an eligibility evaluation.
As wellness-focused adults look beyond traditional NAD+ supplements in 2026, this Pallas Health review examines the clinician-guided daily nasal spray and weekly injection options, $79 and $89 first-month starting prices, ongoing plan costs, and the key details prospective patients are checking before deciding whether to enroll.
For adults already exploring GLP-1 weight management, Pallas Health positions its telehealth program as a lower-cost path worth comparing, with brand-stated compounded semaglutide averaging $199 per month alongside FDA-approved brand-name options listed from $1,069 monthly-subject to licensed-provider evaluation, clinical appropriateness, and important differences buyers should understand before enrolling.